02186.HK
Luye Pharma Group Ltd.
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 1.90
+1.07%Margins
Gross margin
65.3%
EBITDA margin
32.1%
EBIT margin
20.4%
Net margin
8.9%
FCF margin
6.4%
7.0%
Return on equity
3.1%
Return on assets
8.9%
Return on invested capital
0.36x
Asset turnover
HKD 2.1B
Cash from operations
HKD 3.84
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026